title: Important drug information: immune globulin intravenous (human).
authors.affiliation: Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852-1448, USA.
authors.forename: J S
authors.initials: JS
authors.lastname: Epstein
authors.forename: A
authors.initials: A
authors.lastname: Gaines
authors.forename: R
authors.initials: R
authors.lastname: Kapit
authors.forename: R
authors.initials: R
authors.lastname: Pierce
authors.forename: R
authors.initials: R
authors.lastname: Potter
authors.forename: F
authors.initials: F
authors.lastname: Varricchio
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D013395:Sucrose / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016756:Immunoglobulins, Intravenous; D013395:Sucrose